Fate Therapeutics Inc - FATE

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Biological Products, (no Disgnostic Substances)
Latest data: 12/20/2024 10:22:22 PM
EDGAR CIK 0001434316

Buy Breakdown

Total $0

Sell Breakdown

Total $240,389

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
08/06/2024
10b5-1
08/07/2024
Xu Yuan
Director
Sell
-633 @ $4.23
($2,677.59)
 8,669 (-6.80%) Direct
03/04/2024
10b5-1
03/05/2024
Dulac Edward J Iii
Chief Financial Officer
CFO
Sell
-2,447 @ $7.77
($19,013.19)
 101,479 (-2.35%) Direct
01/29/2024
10b5-1
01/30/2024
Dulac Edward J Iii
Chief Financial Officer
CFO
Sell
-1,849 @ $5.00
($9,245.00)
 103,926 (-1.75%) Direct
01/09/2024
01/10/2024
Dulac Edward J Iii
Chief Financial Officer
CFO
Sell
-7,028 @ $4.37
($30,712.36)
 105,775 (-6.23%) Direct
01/09/2024
01/10/2024
Tahl Cindy
General Counsel and Secretary
Officer
Sell
-10,874 @ $4.37
($47,519.38)
 142,361 (-7.10%) Direct
01/09/2024
01/10/2024
Valamehr Bahram
Chief R&D Officer
Officer
Sell
-11,271 @ $4.38
($49,366.98)
 158,069 (-6.66%) Direct
01/09/2024
01/10/2024
Wolchko J Scott
President and CEO
CEO Director
Sell
-14,391 @ $4.37
($62,888.67)
 371,248 (-3.73%) Direct
01/02/2024
10b5-1
01/03/2024
Dulac Edward J Iii
Chief Financial Officer
CFO
Sell
-5,182 @ $3.66
($18,966.12)
 112,803 (-4.39%) Direct